Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: DiaMedica Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
DiaMedica Therapeutics Inc. May 20, 202697.0%
-
DiaMedica Therapeutics Inc. May 15, 202596.9%
-
DiaMedica Therapeutics Inc. May 22, 202497.6%
-
DiaMedica Therapeutics Inc. May 17, 202394.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +10,000 | $1.03 | $10,300 |
| Jan 2, 2026 | DiaMedica Therapeutics Inc. | Grant or award | +10,095 | $8.42 | $85,000 |
| Nov 21, 2025 | DiaMedica Therapeutics Inc. | Option exercise | +12,000 | $2.20 | $26,400 |
| Jan 2, 2025 | DiaMedica Therapeutics Inc. | Grant or award | +15,917 | $5.34 | $84,997 |
| Jan 2, 2024 | DiaMedica Therapeutics Inc. | Grant or award | +21,428 | $2.80 | $59,998 |
Questions about James T. Parsons
What boards is James T. Parsons on?
James T. Parsons sits on the boards of DiaMedica Therapeutics Inc. and Oncolytics Biotech Inc.
How long has James T. Parsons served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.